Progression and OS. Risk of progression (A) and OS (B) according to the result of early assessment of MRD, at 3 to 6 months, after autologous transplantation by consensus PCR. The subset of patients with a negative MRD result (gray line) showed a significantly lower relapse risk and a trend to a longer survival compared with patients with disease positive for MRD (black line).